Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 06:22 am Sale | 2024-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Balyasny Asset Management L.P. | 0 0.000% | -3,085,104 (Position Closed) | Filing History |
| 2024-11-14 06:07 am Purchase | 2024-09-30 | 13G | Leap Therapeutics, Inc. LPTX | Balyasny Asset Management L.P. | 3,085,104 8.060% | 3,085,104 (New Position) | Filing History |
| 2024-10-31 6:29 pm Unchanged | 2024-10-31 | 13D | Leap Therapeutics, Inc. LPTX | BeOne Medicines Ltd. ONC | 1,215,306 3.170% | 0 (Unchanged) | Filing History |
| 2024-10-31 5:40 pm Purchase | 2024-10-31 | 13D | Leap Therapeutics, Inc. LPTX | BeOne Medicines Ltd. ONC | 1,215,306 0.000% | 1,215,306 (New Position) | Filing History |
| 2024-04-25 8:39 pm Purchase | 2024-04-15 | 13G | Leap Therapeutics, Inc. LPTX | Samsara BioCapital, L.P. | 2,442,352 6.400% | 2,442,352 (New Position) | Filing History |
| 2024-04-19 4:31 pm Purchase | 2024-04-10 | 13G | Leap Therapeutics, Inc. LPTX | GILEAD SCIENCES INC. GILD | 5,319,148 13.900% | 5,319,148 (New Position) | Filing History |
| 2024-02-14 4:40 pm Purchase | 2023-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 1,068,497 4.000% | 1,068,497 (New Position) | Filing History |
| 2023-02-14 2:30 pm Sale | 2022-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 672,650 6.800% | -175,000 (-20.65%) | Filing History |
| 2022-02-14 6:55 pm Unchanged | 2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 847,650 9.600% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:05 pm Sale | 2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX | HHLR ADVISORS LTD. | 0 0.000% | -371,624 (Position Closed) | Filing History |
| 2022-02-11 06:30 am Purchase | 2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Artal Participations S.a r.l | 400,000 4.500% | 100,000 (+33.33%) | Filing History |
| 2022-02-10 4:16 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | ELI LILLY & Co LLY | 3,151,605 3.500% | 3,151,605 (New Position) | Filing History |
| 2021-09-28 6:58 pm Purchase | 2021-09-24 | 13D | Leap Therapeutics, Inc. LPTX | BeOne Medicines Ltd. ONC | 1,215,307 13.200% | 254,380 (+26.47%) | Filing History |
| 2021-02-16 4:25 pm Purchase | 2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX | HHLR ADVISORS LTD. | 371,624 6.200% | 371,624 (New Position) | Filing History |
| 2021-02-16 3:42 pm Purchase | 2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 847,650 14.200% | 175,000 (+26.02%) | Filing History |
| 2021-02-12 9:06 pm Unchanged | 2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Artal Participations S.a r.l | 300,000 5.000% | 0 (Unchanged) | Filing History |
| 2021-02-08 10:27 am Sale | 2021-02-05 | 13G | Leap Therapeutics, Inc. LPTX | FMR LLC | 60,600 1.005% | -66,080 (-52.16%) | Filing History |
| 2020-12-28 4:31 pm Purchase | 2020-12-18 | 13G | Leap Therapeutics, Inc. LPTX | Artal Participations S.a r.l | 300,000 5.000% | 300,000 (New Position) | Filing History |